UnitLevel 5Postgraduate

BMS5007 Biotechnology: Commercialising biomedical science

Faculty of Medicine, Nursing and Health Sciences

BMS5007 Biotechnology: Commercialising biomedical science is a level 5, 6-credit-point, postgraduate unit from the Faculty of Medicine, Nursing and Health Sciences, offered in 2021 in Semester 1 and Semester 2 at Clayton. It has no prerequisites.

Credit points
6
Offered in 2021
Semester 1, Semester 2
Clayton
Assessment
No exam
4 tasks

This is the 2021 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review BMS5007.

Requisites

Before BMS5007

No prerequisites or corequisites besides the enrolment rules below.

After BMS5007

No unit lists BMS5007 as a prerequisite in the 2021 handbook.

Enrolment rules

Corequisite: Must be enrolled in a Postgraduate degree

Overview

This unit will examine case studies of medical biotechnology research and development, and will consider the industry context in which biotechnology is commercialised including: industry structure and competition; methods of financing, management approaches; the regulatory environment; product development and its commercial protection via intellectual property; and taking the product to market.

Students will examine case studies to analyse and evaluate the chances of commercialisation success of Australian companies in various phases of development, and present and justify their opinions in the form of class discussions, oral presentations and written business reports.

Offerings in 2021

Teaching periodCampusMode
First semesterClaytonOn campus
Second semesterClaytonOn campus

Assessment

  • 2 x Case study reports (4,500 words total)Threshold hurdle
    55%
  • In-class worksheets
    30%
  • Group oral presentation
    10%
  • Participation in workshop / class discussions
    5%

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Interpret and critically evaluate the pathways from discovery science that lead to innovation and commercialisation of biotechnology innovations;

  2. 2

    Analyse and evaluate the critical role of intellectual property in the commercialisation of biotechnology;

  3. 3

    Apply advanced knowledge of how the major regulatory bodies [e.g. TGA (Therapeutic Goods Administration); FDA (Food & Drug Administration); CTN (Clinical Trial Notification Scheme)] deal with specific innovations in the biotech / medtech sectors;

  4. 4

    Evaluate and critically assess and predict the potential for commercial development and success of a specific biotechnology innovation;

  5. 5

    Systematically build and validate arguments and opinions by sourcing and critically deconstructing relevant material and information, working both independently and as part of a team;

  6. 6

    Effectively communicate complex concepts on scientific content and business processes in written or oral formats.

Workload and teaching

  • Workshops72 hours

On-campus: 4-5 hours of contact per week, which will include a mix of presentations from industry experts and workshop activities.

Off campus: a minimum of 7-8 hours of private study, including preparation of work for discussion and assessment.

Learning resources

Required resources

See Moodle for details about required resources.

Contacts

Chief Examiners
Professor Ramesh Rajan
Unit Coordinators
Professor Ian Cooke

Common questions

What are the prerequisites for BMS5007?

BMS5007 has no prerequisites, but enrolment rules apply.

When is BMS5007 offered?

In 2021, BMS5007 runs in Semester 1 and Semester 2 at Clayton.

Does BMS5007 have an exam?

No. BMS5007 has 4 assessment tasks and no exam.

More details

Credit points
6
Level
5
Study level
Postgraduate
Faculty
Faculty of Medicine, Nursing and Health Sciences
Organisational unit
School of Biomedical Sciences
Type
Coursework
EFTSL
0.125
Student contribution
SCA Band 2
Study abroad
Available